RE: updates9 Aug 2020 20:40
BM if you want intelligent, that won't be me.
Val's website states that we are targeting people who are recovering from covid and preventing any further damage caused by the immune system going into overdrive. I like this, because this way we are, afaik, not competing with the likes of sng (early prevention) or dex (last resort), who are well ahead of us. It's nice to be in our own niche.
The tiny bit of research I've done to check that val's not selling covid-flavoured snake oil took me to this paper on MERS:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024778/
It suggests (to my amateur eye with zero medical background) that VAL201 might have potential as an early treatment as well, but from what I see on VAL website, this is not the avenue the the VAL team are taking. Nevertheless, it is good to know that we have potential. At the end of the day, considering the scale of the covid problem, there should be a piece of the pie for everyone.
£4m mcap is a bit of a joke.